US 9125923
Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy
granted A61KA61K31/70A61K38/212
Quick answer
US patent 9125923 (Use of MiR-26 family as a predictive marker for hepatocellular carcinoma and responsiveness to therapy) held by The United States of America as represented by the Secretary of the Dept. of Health & Human Services expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Dept. of Health & Human Services
- Grant date
- Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/70, A61K38/212, A61P, A61P1/16